Deutsche Bank’s vTv Therapeutics VTVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-159
Closed -$18K 4815
2021
Q1
$18K Sell
159
-17
-10% -$1.67K ﹤0.01% 4398
2020
Q4
$13K Buy
176
+53
+43% +$4.06K ﹤0.01% 4283
2020
Q3
$9K Buy
123
+11
+10% +$967 ﹤0.01% 4206
2020
Q2
$10K Sell
112
-95
-46% -$9.38K ﹤0.01% 4115
2020
Q1
$16K Sell
207
-25
-11% -$2.4K ﹤0.01% 3971
2019
Q4
$15K Buy
+232
New +$14.1K ﹤0.01% 4389
2019
Q3
Sell
-158
Closed -$9K 5305
2019
Q2
$9K Buy
158
+145
+1,115% +$8.7K ﹤0.01% 5002
2019
Q1
$0 Buy
+13
New +$1.26K ﹤0.01% 5464
2018
Q3
Sell
-2,634
Closed -$162K 5574
2018
Q2
$162K Buy
2,634
+1,885
+252% +$139K ﹤0.01% 4368
2018
Q1
$121K Buy
749
+336
+81% +$82.2K ﹤0.01% 4423
2017
Q4
$99K Buy
413
+93
+29% +$20.9K ﹤0.01% 4258
2017
Q3
$75K Sell
320
-627
-66% -$125K ﹤0.01% 4258
2017
Q2
$187K Buy
947
+285
+43% +$59.4K ﹤0.01% 3959
2017
Q1
$173K Sell
662
-55
-8% -$12.5K ﹤0.01% 3668
2016
Q4
$137K Buy
717
+219
+44% +$50.3K ﹤0.01% 3905
2016
Q3
$143K Buy
498
+464
+1,365% +$112K ﹤0.01% 3808
2016
Q2
$7K Buy
34
+6
+21% +$1.38K ﹤0.01% 4965
2016
Q1
$5K Sell
28
-15
-35% -$3.73K ﹤0.01% 4961
2015
Q4
$10K Sell
43
-17
-28% -$4.77K ﹤0.01% 4926
2015
Q3
$15K Buy
+60
New +$20.9K ﹤0.01% 4855

Other funds holding VTVT

Deutsche Bank's VTVT Position: Q2 2021 in Review

Deutsche Bank sold out of vTv Therapeutics (VTVT) in Q2 2021, closing a stake of 159 shares — an estimated $18K sold.

Deutsche Bank first reported a position in VTVT in Q3 2015 and held it in 20 quarters. The position peaked at $187K in Q2 2017. 42 funds tracked by Wall St. Rank hold VTVT as of Q2 2021.

  • Deutsche Bank reported no remaining vTv Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Deutsche Bank sold 159 vTv Therapeutics shares in Q2 2021, an estimated $18K.
  • Deutsche Bank first reported a position in vTv Therapeutics in Q3 2015 and held it in 20 quarters.
  • Deutsche Bank's vTv Therapeutics position peaked at $187K in Q2 2017.
  • 42 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.